SEARCH RESULTS FOR: "Tag: XBI"
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2018(5)
2017(14)
2016(5)
2015(1)
CATEGORIES
5-Minute Market Rundown(1)
Bernie's Content(1)
Best and Worst Stocks(4)
By the Numbers(1)
Editor's Pick(1)
Expectational Analysis(1)
Indexes and ETFs(15)
Indicator of the Week(1)
Intraday Option Activity(10)
Quantitative Analysis(6)
Stock Market News(6)
Stocks On the Move(3)
Technical Analysis(2)
Unusual Trading Activity(1)

11/6/2018 2:30 PM
Midterm elections are taking place across the U.S. today, as you're likely well aware. Last week, we took a broader look at the impact of these mid-cycle votes on stocks. This week, with expectations...
7/17/2018 7:34 AM
As we head into July options expiration week, there's no shortage of catalysts -- both micro and macro -- to drive major stock market moves. Not only are we heading into the thick of second-quarter ea...
5/18/2018 1:36 PM
Many of the top losers on the Nasdaq today are biotech stocks, and options data on the SPDR S&P Biotech ETF (XBI) suggests at least one trader is confident more downside is ahead in the coming weeks....
5/11/2018 2:32 PM
Healthcare stocks are in focus this afternoon, after President Donald Trump unveiled a plan lower drug prices not long ago, entitled "American Patients First." The sector is trading higher following t...
4/30/2018 1:17 PM
The shares of Regeneron Pharmaceuticals Inc (NASDAQ:REGN) are lower today -- earlier touching a three-year low of $298.19 -- extending last week's slide sparked by partner Sanofi's (SNY) disappointin...

Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market commentary, headquartered in Cincinnati, Ohio. Founded in 1981 by industry pioneer Bernie Schaeffer, we've since become a trusted source of research and analysis for individual investors and major financial media outlets alike.







Partner Center